ADMA Biologics Inc - 53 Year Dividend History | ADMA
Historical dividend payout and yield for ADMA Biologics Inc (ADMA) since 1971. The current TTM dividend payout for ADMA Biologics Inc (ADMA) as of December 20, 2024 is $0.00. The current dividend yield for ADMA Biologics Inc as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$4.231B |
$0.258B |
|
ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
